ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$32.88
−0.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 41.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.67x
- Price / sales
- 2143.01x
- Price / cash flow
- -9.48x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 1889.48x
- EV / EBITDA
- -4.13x
- EV / EBIT
- -3.97x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026